Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later

OBJECTIVES: We compared the ability of molecular biomarkers for Alzheimer disease (AD), including amyloid imaging and CSF biomarkers (Aβ(42), tau, ptau(181), tau/Aβ(42), ptau(181)/Aβ(42)), to predict time to incident cognitive impairment among cognitively normal adults aged 45 to 88 years and follow...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Roe, Catherine M., Fagan, Anne M., Grant, Elizabeth A., Hassenstab, Jason, Moulder, Krista L., Maue Dreyfus, Denise, Sutphen, Courtney L., Benzinger, Tammie L.S., Mintun, Mark A., Holtzman, David M., Morris, John C.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Lippincott Williams & Wilkins 2013
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3719431/
https://ncbi.nlm.nih.gov/pubmed/23576620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3182918ca6
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller